Skip to Main Content

Author Details

Damiano Cosimo Rigiracciolo
European Institute of Oncology IRCCS
2015
32
19
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36596361Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitry.J Biol Chem2023
37858338High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.Cell Rep Med2023
37749101GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.Cell Death Discov2023
37461077RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.Breast Cancer Res2023
37434266The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.J Exp Clin Cancer Res2023
35059526Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease.Heliyon2022
35672854Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.J Transl Med2022
35682675G-Protein-Coupled Estrogen Receptor Expression in Rat Uterine Artery Is Increased by Pregnancy and Induces Dilation in a Ca<sup>2+</sup> and ERK1/2 Dependent Manner.Int J Mol Sci2022
35655319Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).J Exp Clin Cancer Res2022
34841688Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer-associated fibroblasts.Clin Transl Med2021
33562737Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression.Cancers (Basel)2021
32325700IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.Cells2020
33291355Correction: Rigiracciolo, D.C., et al., IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. <i>Cells</i> 2020, 9, 1010.Cells2020
32778144The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).J Exp Clin Cancer Res2020
32249708Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets.Expert Opin Ther Targets2020
32143514The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.Cells2020
30728047Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.J Exp Clin Cancer Res2019
30866584GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.Cells2019
29716623miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.J Exp Clin Cancer Res2018
29867564Notch1 Mediates Preconditioning Protection Induced by GPER in Normotensive and Hypertensive Female Rat Hearts.Front Physiol2018
30423928miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs).Cells2018
27341075GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.Mol Carcinog2017
29290975GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer.Oncotarget2017
28924490The lauric acid-activated signaling prompts apoptosis in cancer cells.Cell Death Discov2017
27607345Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.J Cell Physiol2017
26865461Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.AAPS J2016
26646587GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.Oncotarget2016
27384677Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.Oncotarget2016
27220899Estrogen Receptors and Chronic Venous Disease.Eur J Vasc Endovasc Surg2016
26225773SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Cell Death Dis2015
26415222Copper activates HIF-1α/GPER/VEGF signalling in cancer cells.Oncotarget2015
26536245Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway.PLoS One2015
  • 1 - 32 of 32

Recommended Authors

Yasmeen Q Rizvi
University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Xiangnan Kong
Qilu Hospital of Shandong University
Career Start Year 2011
Number of shared co-authors 0
Chenfei Huang
Celularity Inc.
Career Start Year 2011
Number of shared co-authors 0
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Naoto Kondo
Nagoya City University Graduate School of Medical Sciences
Career Start Year 2006
Number of shared co-authors 0
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Hye Jin You
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 1
Mingyao Liu
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 0
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Liana Adam
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 0
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Maria Lucia Hirata Katayama
School of Medicine of Sao Paulo University
Career Start Year 1991
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 6
Nadia Arang
Moores Cancer Center, University of California San Diego
Co-authored papers 3
Simone Lubrano
Moores Cancer Center, University of California
Co-authored papers 3
Dario R Alessi
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Jing Yang
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers 1
Farhoud Faraji
University of California San Diego Health
Co-authored papers 1
Jonathan A Pachter
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Co-authored papers 1
Yuan Zhou
Co-authored papers 1
Sydney I Ramirez
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Frances A Tosto
Co-authored papers 1
Michele Ceribelli
National Center for Advancing Translational Sciences
Co-authored papers 1
Alfredo A Molinolo
University of California
Co-authored papers 1
Julius Bogomolovas
University of California San Diego
Co-authored papers 1
Silvia Coma
Boston Children's Hospital and Dana-Farber Cancer Institute
Co-authored papers 1
Erica Stevenson
Co-authored papers 1
Olivier Harismendy
University of California
Co-authored papers 1
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 1
Daehwan Kim
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Andrew E Aplin
Thomas Jefferson University
Co-authored papers 1
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Daniela Nachmanson
University of California San Diego
Co-authored papers 1
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 1
Robert Saddawi-Konefka
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Release 1.2